LDLR and atherosclerosis: Conversely, ADAM17 deficiency favors overactivation of TNFR2 and atherosclerosis progression in low-density lipoprotein receptor (Ldlr)-deficient mice (35), suggesting that each receptor has distinct modes of signaling and cellular functions.